靶点- |
作用机制- |
在研机构- |
|
在研适应症- |
|
最高研发阶段终止 |
首次获批国家/地区- |
首次获批日期- |
Analgesia Nociceptive Index for Nociception Monitoring in Cirrhotic Patients Undergoing Hepatic Resection: Randomized Control Trial
Nitazoxanide and Lansoprazole Based Regimens for Managing Helicobacter Pylori in Egyptian Patients (NILE Study)
The study will evaluate the eradication rate and tolerability of modified LOAD regimens (three antibiotics and a proton pump inhibitor (lansoprazole)) for management of HP infection in treatment-naive patients as well as patients who failed previous therapies.
Inappropriate Use of Proton Pump Inhibitors in Patients With Liver Cirrhosis
Proton pump inhibitors (PPIs) inappropriate use, in patients with cirrhosis, presents a significant clinical challenge. This study evaluates overprescription and misuse of PPIs in cirrhotic patients. The patterns of use of PPIs will be classified into two groups based on adherence to the proven indications: Group A: Inappropriate use of PPI, Group B: Appropriate use of PPI. We will estimate the prevalence of PPI misuse in cirrhotics and correlate it with different factors.
100 项与 National Liver Institute, Egypt 相关的临床结果
0 项与 National Liver Institute, Egypt 相关的专利(医药)
100 项与 National Liver Institute, Egypt 相关的药物交易
100 项与 National Liver Institute, Egypt 相关的转化医学